Delivery Order SPE2DB25D3109-SPE2DB25FPKWF
Award Date 7/29/25
Potential Completion Date 8/19/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,288.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on July 16, 2025, with completion targeted for August 6, 2025. This non-competitive, non-set-aside award was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Envarsus XR 1 mg tablets (30-count supply) valued at $3,106.80, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Envarsus XR is an extended-release formulation of tacrolimus, an immunosuppressant medication commonly used in...
- The Defense Logistics Agency awarded a delivery order valued at $1.94K to AmerisourceBergen Drug Corp for the supply of Envarsus XR 1 mg tablets (30-count units) on September 5, 2025, with completion scheduled for September 26, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,288.86 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 1 mg tablets (100-count packaging). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle supporting military healthcare programs globally through December 2026....
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Envarsus XR 1 mg tablets (30-count packaging) with a ceiling value of $1,553.40. This is a firm fixed-price delivery order with an ultimate completion date of June 24, 2025, utilizing no set-aside designation. The contract represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion...
- The Defense Logistics Agency awarded a $1,711.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units). This is a non-set-aside competitive award with an ultimate completion date of September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,718.48 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,711.95 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 4 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract represents a pharmaceutical supply delivery executed under a competitively awarded vehicle. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,288.86 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg, a pharmaceutical product used in transplant immunosuppression therapy. The contract, awarded on August 27, 2025, with an ultimate completion date of September 18, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award through open procurement. Performance will occur at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $10,271.70 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...